Estimating the future global dose demand for measles-rubella microarray patches

• Asıl Yazarlar: Melissa Ko (Yazar), Stefano Malvolti (Yazar), Thomas Cherian (Yazar), Carsten Mantel (Yazar), Robin Biellik (Yazar), Courtney Jarrahian (Yazar), Marion Menozzi-Arnaud (Yazar), Jean-Pierre Amorij (Yazar), Hans Christiansen (Yazar), Mark J. Papania (Yazar), Martin I. Meltzer (Yazar), Balcha Girma Masresha (Yazar), Desiree Pastor (Yazar), David N. Durrheim (Yazar), Birgitte Giersing (Yazar), Mateusz Hasso-Agopsowicz (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

BackgroundProgress toward measles and rubella (MR) elimination has stagnated as countries are unable to reach the required 95% vaccine coverage. Microarray patches (MAPs) are anticipated to offer significant programmatic advantages to needle and syringe (N/S) presentation and increase MR vaccination...